Book Sharing for Toddlers With Clefts
Launched by SEATTLE CHILDREN'S HOSPITAL · Mar 28, 2024
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A child's parent or primary caregiver provides a signed and dated informed consent form and permission for their child to participate.
- • A child's parent is willing to comply with all study procedures and be available for the duration of the study.
- • Child is between the ages of 20 to 32 months at the time of enrollment.
- • Child has been diagnosed with isolated cleft palate, with or without cleft lip.
- • Child has received palate repair surgery.
- • The family's preferred language is English or Spanish.
- • The family has access to a smartphone or similar device (e.g., tablets) capable of recording and sending videos.
- Exclusion Criteria:
- • Diagnosed genetic condition associated with developmental delay (e.g., 22q11 deletion).
- • The child has a diagnosis of autism spectrum disorder
- • The child has a tracheostomy tube
- • Child delivered \< 32 weeks' gestation.
- • Child in state custody or foster care.
- • Child with significant sensory impairment (blindness, sensorineural hearing loss).
- • The caregiver speaks a language other than English or Spanish
- • The caregiver does not own a smartphone or similar device capable of recording/sending video
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Seattle, Washington, United States
Patients applied
Trial Officials
Brent Collett, PhD
Principal Investigator
Seattle Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported